| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Thiotepa | Hydroxythiotepa A | VE009563 | View CAS 14056-57-6 |
| Thiotepa | Hydroxythiotepa B | VE009564 | View CAS 121258-29-5 |
Thiotepa Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Thiotepa | Hydroxythiotepa A | VE009563 | View CAS 14056-57-6 |
| Thiotepa | Hydroxythiotepa B | VE009564 | View CAS 121258-29-5 |
| Catalogue No. | VE009564 |
| CAS No. | 121258-29-5 |
| Molecular Formula | C6H14N3OPS |
| Molecular Weight | 207.23 g/mol |
| Parent drug | Thiotepa |
| IUPAC Name | P, P-di(aziridin-1-yl)-N-(2-hydroxyethyl)phosphinothioic amide |
| Synonyms | N/A |
| References | Sci-Hub, Chemistry, pharmacology and pharmacokinetics of N,N′,N′′ -triethylenethiophosphoramide (ThioTEPA). Cancer Treatment Reviews, 26(4), 257–268, 10.1053/ctrv.2000.0170. (2022). Retrieved June 12, 2022, from Sci-hub.se website: https://sci-hub.se/10.1053/ctrv.2000.0170 |
| Status | In-stock |
| ListName | Hydroxythiotepa B |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
